USDA to Grant Bulgaria's Huvepharma Exclusive License For African Swine Fever Vaccine

USDA to Grant Bulgaria's Huvepharma Exclusive License For African Swine Fever Vaccine

The U.S. Department of Agriculture (USDA) said on Monday that it intends to grant Bulgaria's Huvepharma an exclusive license for an experimental African swine fever vaccine.The prospective exclusive license will be royalty-bearing, the USDA's Agricultural Research Service agency said in a statement."The prospective exclusive license may be granted unless, within thirty (30) days from the date of this published Notice, the Agricultural Research Service receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7," the agency said in a statement.The final date for submitting comments is May 22.Huvepharma develops both human and animal health products. The company also manufactures and markets enzymes for food, feed and industrial applications.Huvepharma's manufacturing subsidiary - Biovet, is headquartered in Peshtera, Bulgaria and has three production units in the country and two facilities in the USA. Huvepharma has representative offices and subsidiaries in Bulgaria, Belgium, Poland, China, Taiwan, Thailand, USA, Russia, India, Brazil and Turkey.

Cookies Preferences
Choose Type of Cookies You Accept Using


These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.


These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.


These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.